143 related articles for article (PubMed ID: 9299935)
1. Comparison of analytical performance and biological variability of three bone resorption assays.
Ju HS; Leung S; Brown B; Stringer MA; Leigh S; Scherrer C; Shepard K; Jenkins D; Knudsen J; Cannon R
Clin Chem; 1997 Sep; 43(9):1570-6. PubMed ID: 9299935
[TBL] [Abstract][Full Text] [Related]
2. The effect of calcium supplementation on the circadian rhythm of bone resorption.
Blumsohn A; Herrington K; Hannon RA; Shao P; Eyre DR; Eastell R
J Clin Endocrinol Metab; 1994 Sep; 79(3):730-5. PubMed ID: 8077353
[TBL] [Abstract][Full Text] [Related]
3. Automated and manual assays for urinary crosslinks of collagen: which assay to use?
Seibel MJ; Woitge HW; Farahmand I; Oberwittler H; Ziegler R
Exp Clin Endocrinol Diabetes; 1998; 106(2):143-8. PubMed ID: 9628247
[TBL] [Abstract][Full Text] [Related]
4. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis.
de la Piedra C; Traba ML; Dominguez Cabrera C; Sosa Henríquez M
Clin Chim Acta; 1997 Sep; 265(2):225-34. PubMed ID: 9385464
[TBL] [Abstract][Full Text] [Related]
5. Markers of bone resorption--measurement in serum, plasma or urine?
Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
[TBL] [Abstract][Full Text] [Related]
6. Variability in urinary excretion of bone resorption markers: limitations of a single determination in clinical practice.
Borderie D; Roux C; Toussaint B; Dougados M; Ekindjian OG; Cherruau B
Clin Biochem; 2001 Oct; 34(7):571-7. PubMed ID: 11738394
[TBL] [Abstract][Full Text] [Related]
7. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients.
Maeno Y; Inaba M; Okuno S; Yamakawa T; Ishimura E; Nishizawa Y
Clin Chem; 2005 Dec; 51(12):2312-7. PubMed ID: 16223890
[TBL] [Abstract][Full Text] [Related]
9. Spot urine concentrations of type I collagen cross-linked N-telopeptides and deoxypyridinoline in psoriatic arthritis.
Al-Awadhi AM; Olusi SO; Al-Zaid NS; George S; Sugathan TN
Clin Rheumatol; 1999; 18(6):450-4. PubMed ID: 10638769
[TBL] [Abstract][Full Text] [Related]
10. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
[TBL] [Abstract][Full Text] [Related]
11. Bone resorption parameters [carboxy-terminal telopeptide of type-I collagen (ICTP), amino-terminal collagen type-I telopeptide (NTx), and deoxypyridinoline (Dpd)] in MGUS and multiple myeloma.
Jakob C; Zavrski I; Heider U; Brux B; Eucker J; Langelotz C; Sinha P; Possinger K; Sezer O
Eur J Haematol; 2002 Jul; 69(1):37-42. PubMed ID: 12270060
[TBL] [Abstract][Full Text] [Related]
12. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
Garnero P; Gineyts E; Riou JP; Delmas PD
J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
[TBL] [Abstract][Full Text] [Related]
13. Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks.
Aoshima H; Kushida K; Takahashi M; Ohishi T; Hoshino H; Suzuki M; Inoue T
Bone; 1998 Jan; 22(1):73-8. PubMed ID: 9437516
[TBL] [Abstract][Full Text] [Related]
14. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
15. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
[TBL] [Abstract][Full Text] [Related]
16. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
[TBL] [Abstract][Full Text] [Related]
17. A collection method and high-sensitivity enzyme immunoassay for sweat pyridinoline and deoxypyridinoline cross-links.
Sarno M; Powell H; Tjersland G; Schoendorfer D; Harris H; Adams K; Ogata P; Warnick GR
Clin Chem; 1999 Sep; 45(9):1501-9. PubMed ID: 10471653
[TBL] [Abstract][Full Text] [Related]
18. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
[TBL] [Abstract][Full Text] [Related]
19. Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy.
Abildgaard N; Brixen K; Kristensen JE; Eriksen EF; Nielsen JL; Heickendorff L
Br J Haematol; 2003 Jan; 120(2):235-42. PubMed ID: 12542480
[TBL] [Abstract][Full Text] [Related]
20. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
